| Dr Olusegun A Apoeso, MD | |
|
1 Abrahams Boulevard, Hebrew Home Hospital, West Hartford, CT 06117-3949 | |
| (860) 523-3800 | |
| (860) 523-3949 |
| Full Name | Dr Olusegun A Apoeso |
|---|---|
| Gender | Male |
| Speciality | Geriatric Medicine |
| Experience | 39 Years |
| Location | 1 Abrahams Boulevard, West Hartford, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407838550 | NPI | - | NPPES |
| 001368374 | Medicaid | CT | |
| 010036837C701 | Other | CT | BC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0300X | Internal Medicine - Geriatric Medicine | 036837 (Connecticut) | Primary |
| 207R00000X | Internal Medicine | 036837 (Connecticut) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mount Sinai Hospital | New york, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Icahn School Of Medicine At Mount Sinai | 2264691070 | 2339 |
News Archive
Two of humanity's biggest problems - the climate crisis and abysmal eating habits - can partly be solved by one healthy solution: eating more food from trees, specifically tropical ones.
A team led by scientists at The Scripps Research Institute (TSRI) has identified specific cellular events that appear key to lupus, a debilitating autoimmune disease that afflicts tens of millions of people worldwide. The findings suggest that blocking this pathway in lupus-triggering cells could be a potent weapon against the disease.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the District of Delaware has issued a decision in its litigation over the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Schering-Plough's brain tumor treatment Temodar® (temozolomide). The Court found that U.S. Patent No. 5,260,291 is not enforceable due to prosecution laches and inequitable conduct.
Intellect Neurosciences, Inc a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has received a Notice of Allowance from the United States Patent and Trademark Office related to RV01 and RV02, the Company's two lead vaccine candidates. The Notice of Allowance is a written communication stating that the patent application has been allowed and will be granted as a new patent. RV01 and RV02, generated using the Company's RECALL-VAX technology, have the potential to delay the onset of or prevent Alzheimer's disease in individuals susceptible by age, genetic or other risk factor.
A team of international scientists has demonstrated that therapeutic inhibition of a transcriptional regulator BRD2, required for the endogenous expression of angiotensin-converting enzyme 2 (ACE2), can potentially suppress severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The study is currently available on the bioRxiv* preprint server.
› Verified 2 days ago
| Entity Name | Icahn School Of Medicine At Mount Sinai |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689947160 PECOS PAC ID: 2264691070 Enrollment ID: O20120720000202 |
News Archive
Two of humanity's biggest problems - the climate crisis and abysmal eating habits - can partly be solved by one healthy solution: eating more food from trees, specifically tropical ones.
A team led by scientists at The Scripps Research Institute (TSRI) has identified specific cellular events that appear key to lupus, a debilitating autoimmune disease that afflicts tens of millions of people worldwide. The findings suggest that blocking this pathway in lupus-triggering cells could be a potent weapon against the disease.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the District of Delaware has issued a decision in its litigation over the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Schering-Plough's brain tumor treatment Temodar® (temozolomide). The Court found that U.S. Patent No. 5,260,291 is not enforceable due to prosecution laches and inequitable conduct.
Intellect Neurosciences, Inc a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has received a Notice of Allowance from the United States Patent and Trademark Office related to RV01 and RV02, the Company's two lead vaccine candidates. The Notice of Allowance is a written communication stating that the patent application has been allowed and will be granted as a new patent. RV01 and RV02, generated using the Company's RECALL-VAX technology, have the potential to delay the onset of or prevent Alzheimer's disease in individuals susceptible by age, genetic or other risk factor.
A team of international scientists has demonstrated that therapeutic inhibition of a transcriptional regulator BRD2, required for the endogenous expression of angiotensin-converting enzyme 2 (ACE2), can potentially suppress severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The study is currently available on the bioRxiv* preprint server.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Olusegun A Apoeso, MD 1 Abrahams Boulevard, Hebrew Home Hospital, West Hartford, CT 06117-3949 Ph: (860) 523-3854 | Dr Olusegun A Apoeso, MD 1 Abrahams Boulevard, Hebrew Home Hospital, West Hartford, CT 06117-3949 Ph: (860) 523-3800 |
News Archive
Two of humanity's biggest problems - the climate crisis and abysmal eating habits - can partly be solved by one healthy solution: eating more food from trees, specifically tropical ones.
A team led by scientists at The Scripps Research Institute (TSRI) has identified specific cellular events that appear key to lupus, a debilitating autoimmune disease that afflicts tens of millions of people worldwide. The findings suggest that blocking this pathway in lupus-triggering cells could be a potent weapon against the disease.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the District of Delaware has issued a decision in its litigation over the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Schering-Plough's brain tumor treatment Temodar® (temozolomide). The Court found that U.S. Patent No. 5,260,291 is not enforceable due to prosecution laches and inequitable conduct.
Intellect Neurosciences, Inc a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has received a Notice of Allowance from the United States Patent and Trademark Office related to RV01 and RV02, the Company's two lead vaccine candidates. The Notice of Allowance is a written communication stating that the patent application has been allowed and will be granted as a new patent. RV01 and RV02, generated using the Company's RECALL-VAX technology, have the potential to delay the onset of or prevent Alzheimer's disease in individuals susceptible by age, genetic or other risk factor.
A team of international scientists has demonstrated that therapeutic inhibition of a transcriptional regulator BRD2, required for the endogenous expression of angiotensin-converting enzyme 2 (ACE2), can potentially suppress severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The study is currently available on the bioRxiv* preprint server.
› Verified 2 days ago
Dr. Varalakshmi Niranjan, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 65 Kane St, West Hartford, CT 06119 Phone: 860-523-6436 Fax: 860-523-3775 | |
Dr. Gregory C Walsh, MD Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 20 Isham Rd, Suite 150, West Hartford, CT 06107 Phone: 860-527-1669 Fax: 860-293-0783 | |
Myra Rosenstein, MD Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 65 Kane St, Internal Medicine, West Hartford, CT 06119 Phone: 860-523-6436 Fax: 860-523-3775 | |
Dr. William James Pickering, MD Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 1064 Farmington Ave, West Hartford, CT 06107 Phone: 860-561-3890 Fax: 860-521-8040 | |
Dr. Pallavi Lakra, Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 336 N Main St, West Hartford, CT 06117 Phone: 860-232-4891 | |
John Papandrea, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 41 N Main St, Suite 300, West Hartford, CT 06107 Phone: 860-313-0448 Fax: 860-313-1464 | |
Donald S Ruffett, MD Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 345 N Main St Fl 1, West Hartford, CT 06117 Phone: 860-547-1489 Fax: 860-548-9105 |